Wall Street continues to get bullish on the small cap.
In this video, Motley Fool health-care analyst David Williamson takes a closer look at Sarepta's (SRPT +1.84%) big move on Friday. Wall Street is starting to wake up to this small biotech story and several key catalysts in the coming months could attract even more attention.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
